Anika Therapeutics (ANIK) Change in Taxes (2011 - 2026)
Anika Therapeutics (ANIK) reported Change in Taxes of $1.2 million for Q1 2026, up 9253.85% year-over-year from $12722.0 in Q1 2025, and up 255.22% quarter-over-quarter from $335000.0 in Q4 2025.
Anika Therapeutics (ANIK) Change in Taxes (2011 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has 16 years of Change in Taxes data on file, last reported at $1.2 million in Q1 2026.
- Change in Taxes for Q1 2026 came in at $1.2 million, up 9253.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (up 90.21% YoY), and the FY2025 annual result was -$134000.0, down 120.15% from the prior year.
- Change in Taxes rose to $1.2 million in Q1 2026 per ANIK's latest filing, from $335000.0 in the prior quarter.
- Over five years, Change in Taxes peaked at $1.3 million in Q2 2022 and troughed at -$761000.0 in Q2 2024.
- A 5-year average of $216941.2 and a median of $90000.0 in 2024 frame the typical range for Change in Taxes.
- The sharpest annual moves came in 2023 and 2026: Change in Taxes sank 130.96% in 2023, then soared 9253.85% in 2026.
- A 5-year view of Change in Taxes shows it stood at $1.0 million in 2022, then tumbled by 58.38% to $422000.0 in 2023, then sank by 77.01% to $97000.0 in 2024, then jumped by 245.36% to $335000.0 in 2025, then surged by 255.22% to $1.2 million in 2026.
- Business Quant data shows ANIK's Change in Taxes at $1.2 million in Q1 2026, $335000.0 in Q4 2025, and -$21000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 73.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 119.80 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Anika Therapeutics | 197.89 Mn | 131.10 Mn | 19.00 Mn | 1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.19 Mn |
| Mar 31, 2026 | 1.19 Mn |
| Dec 31, 2025 | 335,000.00 |
| Dec 31, 2025 | 335,000.00 |
| Sep 30, 2025 | -21,000.00 |
| Sep 30, 2025 | -21,000.00 |
| Jun 30, 2025 | -435,000.00 |
| Jun 30, 2025 | -435,000.00 |
| Mar 31, 2025 | -13,000.00 |
| Mar 31, 2025 | -13,000.00 |
| Dec 31, 2024 | 97,000.00 |
| Dec 31, 2024 | 97,000.00 |
| Sep 30, 2024 | 1.24 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | -761,000.00 |
| Jun 30, 2024 | -761,000.00 |
| Mar 31, 2024 | 90,000.00 |
| Mar 31, 2024 | 90,000.00 |
| Dec 31, 2023 | 422,000.00 |
| Dec 31, 2023 | 422,000.00 |